SPYRE THERAPEUTICS, INC. Public Float
SPYRE THERAPEUTICS, INC. (SYRE) had Public Float of $1.10 billion as of 2025-06-30, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-19
- 2025-06-30: Entity Public Float $1.10B.
- 2024-06-30: Entity Public Float $1.10B.
- 2023-06-30: Entity Public Float $26.20M.
- 2022-06-30: Entity Public Float $30.30M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $1.10B 10-K · filed 2026-02-19 |
| 2024-06-30 | $1.10B 10-K · filed 2025-02-27 |
| 2023-06-30 | $26.20M 10-K/A · filed 2024-11-18 |
| 2022-06-30 | $30.30M 10-K · filed 2023-03-02 |
| 2021-06-30 | $337.40M 10-K · filed 2022-03-08 |
| 2020-06-30 | $386.00M 10-K · filed 2021-03-18 |
| 2019-06-30 | $177.70M 10-K · filed 2020-02-24 |
| 2018-06-30 | $199.10M 10-K · filed 2019-03-07 |
| 2017-06-30 | $50.60M 10-K · filed 2018-03-13 |
| 2016-06-30 | $24.60M 10-K · filed 2017-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |